TY - JOUR AU - Karlsson, J. O. G. AU - Ignarro, L. J. AU - Lundström, I. AU - Jynge, P. AU - Almén, T. PY - 2015 DA - 2015// TI - Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties JO - Drug Discov Today VL - 20 UR - https://doi.org/10.1016/j.drudis.2014.11.008 DO - 10.1016/j.drudis.2014.11.008 ID - Karlsson2015 ER - TY - STD TI - Karlsson J, Reineke K, Kurz T, Andersson R, McLaughlin C, Jacobsson S, Näsström J. Calmangafodipir, a new chemical entity, and other metal complexes, method of preparation, compositions, and methods of treatment. US 9187509 B2. Nov 17, 2015. ID - ref2 ER - TY - JOUR AU - Dear, J. PY - 2019 DA - 2019// TI - Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial published study protocol for a randomised controlled trial JO - Trials VL - 20 UR - https://doi.org/10.1186/s13063-018-3134-1 DO - 10.1186/s13063-018-3134-1 ID - Dear2019 ER - TY - JOUR AU - Brurok, H. AU - Ardenkjaer-Larsen, J. H. AU - Hansson, G. AU - Skarra, S. AU - Berg, K. AU - Karlsson, J. O. AU - Laursen, I. AU - Jynge, P. PY - 1999 DA - 1999// TI - Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? JO - Biochem Biophys Res Commun VL - 254 UR - https://doi.org/10.1006/bbrc.1998.0131 DO - 10.1006/bbrc.1998.0131 ID - Brurok1999 ER - TY - JOUR AU - Karlsson, J. O. G. AU - Kurz, T. AU - Flechsig, N. J. AU - Andersson, R. G. G. PY - 2012 DA - 2012// TI - Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct JO - Transl Oncol VL - 5 UR - https://doi.org/10.1593/tlo.12238 DO - 10.1593/tlo.12238 ID - Karlsson2012 ER -